![Pic therapeutics](/api/images/company-pic/0-1281834-company.png)
Contate-nos
Sobre companhia
PIC Therapeutics is a biotechnology company focused on transforming the treatment of cancer through the selective modulation of oncogene translation. The company is modulating oncogene translation to dramatically improve cancer patient outcomes. Their precision-based therapeutics target the “master switch” of cancer signaling pathways, selectively blocking oncogene protein production by modulating the Pre-Initiation Complex (PIC) that drives their mRNA translation. Its selective approach has the potential to simultaneously modulate multiple oncogenic drivers leading to a powerful new generation of cancer-treating therapeutics. PIC Therapeutics was founded in 2016 and is headquartered in
US
Desconhecido
Empresa não verificada
Transparência de negócios
- Não verificou as informações da empresa
- Peça avaliações aos seus clientes
- Não respondeu a comentários negativos